Patent details

EP3300721 Title: PROPYLENE GLYCOL-CONTAINING PEPTIDE FORMULATIONS WHICH ARE OPTIMAL FOR PRODUCTION AND FOR USE IN INJECTION DEVICES

Basic Information

Publication number:
EP3300721
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP171965015
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PROPYLENE GLYCOL-CONTAINING PEPTIDE FORMULATIONS WHICH ARE OPTIMAL FOR PRODUCTION AND FOR USE IN INJECTION DEVICES
French Title of Invention:
FORMULATIONS DE PEPTIDES CONTENANT DU PROPYLÈNE GLYCOL QUI SONT OPTIMALES POUR LA PRODUCTION ET DESTINÉES À ÊTRE UTILISÉES DANS DES DISPOSITIFS D'INJECTION
German Title of Invention:
PROPYLENGLYKOLHALTIGE PEPTIDFORMULIERUNGEN, DIE ZUR HERSTELLUNG UND ZUM EINSATZ IN EINSPRITZVORRICHTUNGEN OPTIMAL SIND
SPC Number:

Dates

Filing date:
18/11/2004
Grant date:
06/03/2019
EP Publication Date:
04/04/2018
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
06/03/2019
EP B1 Publication Date:
06/03/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
18/11/2019
Expiration date:
18/11/2024
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
27/02/2019
 
 

Name:
Novo Nordisk A/S
Address:
Novo Allé, 2880 Bagsværd, Denmark (DK)

Inventor

1

Name:
Engelund, Dorthe Kot
Address:
Denmark (DK)

2

Name:
Pedersen, Tina Bjeldskov
Address:
Denmark (DK)

3

Name:
Bonde, Claude
Address:
Denmark (DK)

Priority

Priority Number:
200301719
Priority Date:
20/11/2003
Priority Country:
Denmark (DK)

Classification

IPC classification:
A61K 9/00; A61K 38/26; A61K 38/28; A61K 47/20; A61K 47/26; A61K 47/10; A61K 47/18;

Publication

European Patent Bulletin

1

Issue number:
201910
Publication date:
06/03/2019
Description:
Grant (B1)

2

Issue number:
202002
Publication date:
08/01/2020
Description:
Opposition procedure started

3

Issue number:
202003
Publication date:
15/01/2020
Description:
Opposition procedure started

4

Issue number:
202019
Publication date:
06/05/2020
Description:
Opposition deemed not to have been filed

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages